Mycophenolate Mofetil
This immunosuppressant medication is used after organ transplantation to prevent the body from rejecting the new organ. It works by reducing the activity of white blood cells that would otherwise attack the transplanted tissue, and is usually taken alongside other anti-rejection drugs.
Peso molecular
433,5000 g/mol
LogP
3,20
TPSA
94,50 Ų
Regla de cinco de Lipinski
Cumple
Áreas terapéuticas
Mecanismo de acción
Suppresses the immune system by inhibiting T-cell activation, lymphocyte proliferation, or cytokine production. This prevents immune-mediated tissue damage and graft rejection.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Suppresses the immune system by inhibiting T-cell activation, lymphocyte proliferation, or cytokine production. This prevents immune-mediated tissue damage and graft rejection.
Estructura 2D
Cite this structure
Embed this structure
SMILES
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2
InChI
InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+
Molecular Formula
C23H31NO7
HBD / HBA
1 / 8
Enlaces Rotables
10
Átomos Pesados
31
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
This immunosuppressant medication is used after organ transplantation to prevent the body from rejecting the new organ. It works by reducing the activity of white blood cells that would otherwise attack the transplanted tissue, and is usually taken alongside other anti-rejection drugs.
Suppresses the immune system by inhibiting T-cell activation, lymphocyte proliferation, or cytokine production. This prevents immune-mediated tissue damage and graft rejection.
Yes, Mycophenolate Mofetil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1456. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5281078. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="mycophenolate-mofetil"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/mycophenolate-mofetil/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/mycophenolate-mofetil/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/mycophenolate-mofetil/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="mycophenolate-mofetil"></drugfyi-drug>